Wegovy uses semaglutide, a GLP-1 receptor agonist that mimics the incretin hormones your body releases when you eat
While the low starting dose of 0.25 mg is specifically designed to mitigate these adverse effects, many patients will still experience some mild discomfort as their system adapts
Pharmaceuticals Memorable moments in 2023 The moments, numbers, and news that the C&EN team found noteworthy this year by Laura Howes Open-source drug discovery prepared for the next pandemic New antiviral drug leads were reported by an open-source drug discovery effort, the COVID Moonshot Consortium ( Science 2023, DOI: 10.1126/science.abo7201)
It works by telling the body to release insulin, which lowers blood sugar
GLP-1RA FAERS analyses (class-level): FAERS analyses across GLP-1 receptor agonists highlight dehydration/volume depletion as an area needing attention and demonstrate sex differences in some adverse event patterns in broader AE categories
Because lysine at position 34 would compete with position 26 for the fatty acid chain attachment described below
